Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States

Abstract Introduction In the post-pandemic era, people with underlying medical conditions continue to be at increased risk for severe COVID-19 disease, yet COVID-19 vaccination uptake remains low. This study estimated the clinical and economic impact of updated 2023/24 Moderna COVID-19 vaccination a...

Full description

Saved in:
Bibliographic Details
Main Authors: Keya Joshi, Mariia Dronova, Ewelina Paterak, Van H. Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, Ekkehard Beck
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Infectious Diseases and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40121-025-01128-z
Tags: Add Tag
No Tags, Be the first to tag this record!